1st Circ. Won't Rethink Ending Sarepta Securities Suit

1st Circ. Won't Rethink Ending Sarepta Securities Suit

The First Circuit refused Wednesday to reconsider its August decision upholding the dismissal of a putative securities class action accusing drugmaker Sarepta Therapeutics Inc. of misleading investors over the possibility of government approval for its ...read more

  • Tags: